-
Occidental Q1 2026: adj EPS $1.06, debt cut $7.1B to $13.3B
Reported EPS $3.13 (gain on OxyChem sale); adjusted EPS from continuing ops $1.06.
-
CEO Vicki Hollub to retire June 1, 2026; COO Richard Jackson named successor
Vicki Hollub to retire as President and CEO effective June 1, 2026; will remain on Board.
-
Occidental pre-announces Q1 2026 factors: diluted shares 1,006.9M; oil realized $69.91/Bbl
Average diluted shares outstanding for Q1 2026: 1,006.9M.
-
Occidental upsizes tender offer to $1.2B, accepts early tenders for notes
Increased aggregate cap from $700M to $1.2B; accepted $1.2B in tenders at March 4, 2026 early deadline.
-
Occidental commences $700M debt tender offer and consent solicitation on five note series
Tender offers for five series: 0% 2036 notes, 6.125% 2031, 6.625% 2030, 7.2% 2029 debentures, 7.95% 2029 debentures.
-
Occidental discloses 2025 annual results; detailed figures not included in filing
The company announced financial results for the fiscal year ended December 31, 2025.
-
Occidental issues Q4 2025 earnings considerations; OxyChem sale closed Jan 2, 2026
OxyChem sale completed Jan 2, 2026; results reported as discontinued ops for all periods.
-
Occidental completes $9.7B sale of OxyChem to Berkshire Hathaway, cuts debt $6.5B
Closed Jan 2, 2026; all-cash consideration of $9.7B subject to working capital adjustments.
-
Occidental Q3 net income $661M ($0.65/diluted), production beat guidance at 1,465 Mboed
Net income $661M ($0.65 diluted EPS); adjusted EPS $0.64; operating cash flow $2.8B.
-
OXY provides Q3 2025 operational update: avg oil realized $64.78/Bbl, shares 1,003.1M
Average diluted shares outstanding 1,003.1M for Q3 2025.
-
Occidental sells OxyChem to Berkshire Hathaway for $9.7B all-cash
Deal value $9.7B, subject to customary adjustments for cash, debt, and working capital.
-
Occidental promotes Richard A. Jackson to COO, effective Oct 1, 2025
Jackson named Senior VP & COO; oversees global oil & gas, low-carbon tech, midstream, marketing, HSE.
-
Berkshire Hathaway to acquire Occidental's OxyChem for $9.7B cash
Berkshire Hathaway to acquire OxyChem from Occidental for $9.7B in all-cash transaction.
-
Occidental Q2 net income $288M, adjusted EPS $0.39; cuts 2025 capex guidance $100M
Q2 net income attributable to common stockholders $288M ($0.26 diluted EPS); adjusted income $396M ($0.39 adjusted EPS).
-
Occidental files pro forma financials for CrownRock acquisition for FY 2024
Pro forma combined revenue of $28.3B for year ended Dec 31, 2024.
-
Occidental files prospectus supplement for warrant exercises; 31.99M warrants outstanding
Filed prospectus supplement under shelf registration for common stock issuable upon warrant exercise.
-
Occidental provides preliminary Q2 2025 guidance: Gulf production curtailed, tax rate up
Gulf of America sales volumes estimated at 125 Mboed due to third-party constraints and maintenance; total production within guidance.
-
Occidental Q1 net income $766M ($0.77 EPS), adjusted EPS $0.87; cuts capex guide $200M
Net income $766M ($0.77 diluted); adjusted income $860M ($0.87 diluted) for Q1 2025.
-
Occidental annual meeting elects all 10 director nominees; all proposals pass
All 10 director nominees elected with support between 95.85% and 98.26%.
-
Occidental Q1 2025 preview: avg oil $71.07/Bbl, shares 982.9M
Average diluted shares outstanding for Q1 2025: 982.9 million.
-
Occidental temporarily reduces warrant exercise price from $22 to $21.30 through March 31
Exercise price for publicly traded warrants reduced to $21.30 if exercised under Offer to Exercise.
-
Occidental Petroleum reports 2024 results; details unavailable in filing text
Press release issued February 18, 2025 for the year ended December 31, 2024.
-
Occidental reports preliminary Q4 2024 realized prices and diluted share count
Average diluted shares outstanding for Q4 2024 were 983.9 million.
-
Occidental Q3 2024: EPS $0.98; production 1,412 Mboed above guidance; $4B debt repaid
Net income $964M ($0.98 diluted EPS); adjusted income $977M ($1.00 adjusted EPS).
-
Occidental amends bylaws to align with Delaware law, update stockholder nomination and indemnification rules
Removed provision that Board's determination on stockholder special meeting requests was 'conclusive and binding'.
-
Occidental warns shareholders against TRC Capital mini-tender offer at 4.45% discount
TRC Capital offers to buy up to 2M shares (0.2% outstanding) at $51.51, a 4.45% discount to $53.91 close.
-
Occidental provides Q3 2024 preliminary metrics: shares 975.7M, oil $75.33/bbl
Average diluted shares outstanding: 975.7 million for Q3 2024.
-
CrownRock Holdings sells 29.56M OXY shares in underwritten public offering
CrownRock Holdings, L.P. sold 29,560,619 shares of Occidental common stock in the offering.
-
Occidental files updated CrownRock financials for H1 2024; pro forma data included
CrownRock net income $616M on revenues $1.26B for six months ended June 30, 2024.
-
Occidental Q2 net income $1.0B, EPS $1.03; production exceeds guidance
Net income $1.0B ($1.03 diluted EPS); operating cash flow $2.4B; free cash flow before working capital $1.3B.
-
Occidental terminates exchange offer for up to $376M CrownRock Notes
Terminated exchange of any/all outstanding 5.000% CrownRock Notes due 2029 for new Occidental notes plus cash.
-
Occidental completes $12.4B acquisition of CrownRock, closing on August 1, 2024
Aggregate consideration $12.4B: $9.4B cash, 29.56M OXY shares, assumption of $1.2B CrownRock debt.
-
Ecopetrol decides not to acquire 30% stake in CrownRock assets from Occidental
Ecopetrol informed Occidental on July 31, 2024 that it will not acquire any interest in the CrownRock assets.
-
Occidental issues $5B in senior notes to fund CrownRock acquisition and refinancing
Issued $5B in senior notes: $600M 5.000% due 2027, $1.2B 5.200% due 2029, $1B 5.375% due 2032, $1.2B 5.550% due 2034, $1B 6.050% due 2054.
-
HSR clearance for CrownRock deal; Ecopetrol may buy 30% stake for ~$3.6B
HSR waiting period for CrownRock acquisition expired; closing expected August 2024.
-
Occidental launches exchange offer for up to $376M of CrownRock 5% notes due 2029
Occidental commenced private exchange offer for any and all outstanding $376M CrownRock 5% Senior Notes due 2029; offers new Occidental notes and cash.
-
Occidental provides Q2 2024 preliminary metrics: diluted shares 958.9M, oil realized $79.89/Bbl
Q2 2024 diluted shares outstanding estimated at 958.9 million.
-
Occidental Q1 net income $718M ($0.75 EPS); adjusted EPS $0.63; beats midstream/chem guidance
Net income $718M ($0.75 diluted EPS); adjusted income $604M ($0.63 adjusted EPS).
-
Occidental shareholders elect all 10 director nominees, approve say-on-pay and KPMG ratification
All 10 board nominees elected with 97-99% support; broker non-votes of ~112M shares.